Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
Milton S. Hershey Medical Center
Milton S. Hershey Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Virginia
Virginia Commonwealth University
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
University of California, Davis
Millennium Pharmaceuticals, Inc.